Back
Monopar Therapeutics Stock Price Chart
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
MNPR
Monopar Therapeutics
Last Price:
$41.00
Seasonality Move:
-14.17%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.11 | Buy |
| 20-day SMA: | 34.28 | Buy |
| 50-day SMA: | 37.57 | Buy |
| 200-day SMA: | 16.87 | Buy |
| 8-day EMA: | 38.3 | Buy |
| 20-day EMA: | 36.79 | Buy |
| 50-day EMA: | 34.94 | Buy |
| 200-day EMA: | 21.55 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 58.68 | Buy |
| Chaikin Money Flow: | 12278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.98 - 39.9) | Buy |
| Bollinger Bands (100): | (19.38 - 39.44) | Buy |
Monopar Therapeutics Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 41.39 while MNPR 8-day simple moving average is 39.11, which is a Buy signal.
-
The stock price of MNPR is 41.39 while Monopar Therapeutics 20-day SMA is 34.28, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 37.57 while MNPR share price is 41.39, making it a Buy technically.
-
MNPR stock price is 41.39 and Monopar Therapeutics 200-day simple moving average is 16.87, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
53
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $41.39. The Score for MNPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
218.4M
Price in USD:
41.39
Share Volume:
25.5K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Buy
53
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 41.39 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 41.39 while MNPR 8-day exponential moving average is 38.30, which is a Buy signal.
-
The stock price of MNPR is 41.39 while Monopar Therapeutics 20-day EMA is 36.79, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 34.94 while MNPR share price is 41.39, making it a Buy technically.
-
MNPR stock price is 41.39 and Monopar Therapeutics 200-day simple moving average is 21.55, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 0.85, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 58.68, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (29.98 - 39.9), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (19.38 - 39.44), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.